These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32796271)

  • 21. Expression of CYLD and NF-kappaB in human cholesteatoma epithelium.
    Byun JY; Yune TY; Lee JY; Yeo SG; Park MS
    Mediators Inflamm; 2010; 2010():796315. PubMed ID: 20414373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of MMP-14 and its role in bone destruction in middle ear cholesteatoma: A prospective observational study.
    Lei Y; An J; Ren Q; Wang M; Gao M
    Medicine (Baltimore); 2023 Oct; 102(43):e35538. PubMed ID: 37904429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
    Huang CC; Chen CT; Huang TS; Shinoda H
    Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research progress of the cholesteatoma and proliferation pathways].
    Wang J; Wei XL
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Sep; 53(9):703-708. PubMed ID: 30293269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Hyperproliferation Mechanism of Cholesteatoma Based on Proteomics: SNCA Promotes Autophagy-Mediated Cell Proliferation Through the PI3K/AKT/CyclinD1 Signaling Pathway.
    Gao M; Xiao H; Liang Y; Cai H; Guo X; Lin J; Zhuang S; Xu J; Ye S
    Mol Cell Proteomics; 2023 Sep; 22(9):100628. PubMed ID: 37532176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
    Feng YS; Si Y; Zhang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Keratinocyte growth factor receptor (KGF-R) in cholesteatoma tissue.
    Barbara M; Raffa S; Murè C; Manni V; Ronchetti F; Monini S; Torrisi MR
    Acta Otolaryngol; 2008 Apr; 128(4):360-4. PubMed ID: 18368565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Middle ear cholesteatoma: present-day concepts of etiology and pathogenesis].
    Lesinskas E; Kasinskas R; Vainutiene V
    Medicina (Kaunas); 2002; 38(11):1066-71; quiz 1141. PubMed ID: 12532718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratinocyte Growth Factor Stimulates Growth of p75
    Yamamoto-Fukuda T; Akiyama N; Tatsumi N; Okabe M; Kojima H
    Am J Pathol; 2022 Nov; 192(11):1573-1591. PubMed ID: 36210210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The growth-promoting effect of KGF on limbal epithelial cells is mediated by upregulation of DeltaNp63alpha through the p38 pathway.
    Cheng CC; Wang DY; Kao MH; Chen JK
    J Cell Sci; 2009 Dec; 122(Pt 24):4473-80. PubMed ID: 19920075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.
    Ho KY; Yeh TS; Huang HH; Hung KF; Chai CY; Chen WT; Tsai SM; Chang NC; Chien CY; Wang HM; Wu YJ
    Int J Mol Sci; 2013 Jul; 14(7):14439-59. PubMed ID: 23852020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity.
    Yamamoto-Fukuda T; Terakado M; Hishikawa Y; Koji T; Takahashi H
    Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1173-8. PubMed ID: 18246360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.
    Schürmann M; Oppel F; Shao S; Volland-Thurn V; Kaltschmidt C; Kaltschmidt B; Scholtz LU; Sudhoff H
    Cell Commun Signal; 2021 Feb; 19(1):25. PubMed ID: 33627146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
    Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
    Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
    Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media.
    Yamamoto-Fukuda T; Takahashi H; Terakado M; Hishikawa Y; Koji T
    Otol Neurotol; 2010 Jul; 31(5):745-51. PubMed ID: 20502381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of PTHrP and RANKL in acquired middle ear cholesteatoma epithelium.
    Xie S; Pan Z; Yin T; Ren J; Liu W
    Acta Otolaryngol; 2020 May; 140(5):351-355. PubMed ID: 32108533
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.
    Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL
    J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
    Zhang E; Gong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.